Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.45 USD | +7.18% |
|
+5.03% | +71.88% |
| Market Cap | 344M 464M 405M 374M 651M 44.61B 662M 4.46B 1.75B 21.8B 1.74B 1.7B 75.15B | P/E 2026 * |
-16.3x | P/E 2027 * | -14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 197M 266M 233M 215M 374M 25.6B 380M 2.56B 1.01B 12.51B 999M 977M 43.14B | EV / Sales 2026 * |
79.1x | EV / Sales 2027 * | 27.4x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | +7.18% | ||
| 1 week | +5.03% | ||
| Current month | -4.83% | ||
| 1 month | +49.29% | ||
| 3 months | +43.54% | ||
| 6 months | +87.95% | ||
| Current year | +71.88% |
| 1 week | 8.91 |  | 10.73 |
| 1 month | 6.52 | | 11.06 |
| Current year | 4.19 | | 11.06 |
| 1 year | 4.19 | | 11.06 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-06 | Sell | 865,112 | 0.6105% | |||
| 01-02 | Free | Director | 90,000 | 0.0635% | ||
| 01-02 | Free | Chief Financial Officer | 375,000 | 0.2646% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.18% | +5.03% | +61.02% | +78.02% | 461M | |
| -0.17% | +1.47% | +3.16% | +7.43% | 50.35B | |
| -0.29% | -2.81% | +387.81% | +593.12% | 39.32B | |
| -0.49% | +1.48% | +31.16% | -6.58% | 34.69B | |
| +1.53% | +3.11% | +15.41% | +57.28% | 34.08B | |
| +1.68% | -1.40% | +4.23% | +27.34% | 26.63B | |
| +1.13% | -3.11% | - | - | 16.49B | |
| -1.29% | -0.52% | +69.24% | +113.95% | 15.31B | |
| +0.43% | +3.34% | +14.96% | +17.98% | 13.8B | |
| +2.45% | +3.99% | +18.20% | -29.77% | 12.87B | |
| Average | +1.28% | -0.76% | +67.24% | +95.42% | 24.4B | |
| Weighted average by Cap. | +0.50% | -0.32% | +82.00% | +122.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 3.37M 2.94M 2.71M 4.73M 324M 4.81M 32.41M 12.72M 158M 12.64M 12.36M 546M | 3.44M 4.64M 4.06M 3.74M 6.52M 447M 6.63M 44.69M 17.53M 218M 17.43M 17.05M 752M |
| Net income | -50.34M -67.9M -59.36M -54.76M -95.38M -6.53B -97.01M -654M -257M -3.19B -255M -249M -11.01B | -84.67M -114M -99.84M -92.1M -160M -10.99B -163M -1.1B -431M -5.37B -429M -419M -18.51B |
| Net Debt | -146M -198M -173M -159M -277M -19.01B -282M -1.9B -746M -9.29B -742M -726M -32.02B | -249M -336M -294M -271M -473M -32.37B -481M -3.24B -1.27B -15.82B -1.26B -1.24B -54.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | $10.45 | +7.18% | 791,844 |
| 14/07/26 | $9.750 | +4.95% | 338,977 |
| 13/07/26 | $9.290 | +2.20% | 233,638 |
| 10/07/26 | $9.090 | -7.81% | 365,407 |
| 09/07/26 | $9.860 | -0.90% | 232,796 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
